FindTrial
Sign In

To determine the clinical efficacy and adverse effect of Platelet rich plasma in treatment of different types of striae.

Effect of Platelet Rich PLasma (PRP) for treatment of striae

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037672
Enrollment
54
Registered
2021-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L909- Atrophic disorder of skin, unspecified

Interventions

Intervention1: platelet rich plasma group: 3 sittings of PRP GIVEN MONTHLY WITH FOLLOWUP FOR 3 MONTHS Control Intervention1: NORMAL SALINE GROUP: 3 SITTINGS OF NS GIVEN MONTHLY WITH MONTHLY FOLLOWUP

Sponsors

Department of dermatology and venereology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group 18 -50 years 2. Striae of any type with bilateral distribution.

Exclusion criteria

Exclusion criteria: 1.Not able give consent or understand protocol 2.Platelet disorder or anemia or malignacies 3.HIV or Hepatitis B or C patients. 4.Immunocompromised patients 5.Active skin disease or skin infection 6.On antiplatelet drugs or NSAIDS Drugs or treatment in form of topical or oral for striae within past 6 months

Design outcomes

Primary

MeasureTime frame
maximum width of striae over 6 monthsTimepoint: followup at every 4 weeks till 6 months—

Secondary

MeasureTime frame
patient assessment score Timepoint: monthlfollowup for every 6 months—

Countries

India

Contacts

Public ContactDr Ankita Kumari

Institute of Medical Sciences

drsatyendraderma@gmail.com8601880466

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026